Coronary collaterals in patients with ST-elevation myocardial infarction presenting late after symptom onset

Anne Freund1,2,3, Thomas Stiermaier4,5, Suzanne de Waha-Thiele4,5

  • 1Heart Center Leipzig, Department of Internal Medicine/Cardiology, University of Leipzig, Strümpellstr. 39, 04289, Leipzig, Germany. anne.freund@medizin.uni-leipzig.de.

Insights

Well-developed coronary collaterals in ST-elevation myocardial infarction (STEMI) patients presenting late after symptom onset significantly reduce infarct size and long-term mortality. This highlights the prognostic importance of collateral circulation in STEMI outcomes.

Area of Science:

  • Cardiology
  • Cardiovascular Research
  • Interventional Cardiology

Background:

  • The prognostic role of coronary collaterals in ST-elevation myocardial infarction (STEMI) is debated, particularly in patients with delayed presentation.
  • Existing research often focuses on early STEMI presentation, leaving the impact of collaterals in late-presenting patients less understood.

Purpose of the Study:

  • To investigate the prognostic significance of coronary collateralization in STEMI patients presenting with prolonged ischemia, 12-48 hours after symptom onset.
  • To assess the impact of collateralization on microvascular obstruction, infarct size, and long-term mortality in this patient group.

Main Methods:

  • Subanalysis of a randomized trial involving STEMI patients presenting 12-48 hours post-symptom onset.
  • Assessment of coronary collateralization using the Rentrop classification in 95 patients with TIMI flow grade 0 or 1 prior to PCI.
  • Magnetic resonance imaging (MRI) to quantify microvascular obstruction and infarct size.
  • Four-year follow-up to determine long-term mortality.

Main Results:

  • 65% of patients had poor collateralization (Rentrop grade 0 or 1), while 35% had well-developed collaterals (Rentrop grade 2 or 3).
  • Patients with well-developed collaterals showed significantly smaller areas of microvascular obstruction (2.1% vs. 4.5% LV, p=0.03) and infarct size (27.9% vs. 34.8% LV, p=0.047).
  • Four-year mortality was substantially lower in patients with good collateralization (6% vs. 25%, p=0.02).
  • Poor collateralization independently predicted long-term mortality, alongside cardiogenic shock and unsuccessful PCI.

Conclusions:

  • Sufficient coronary collateralization positively influences microvascular obstruction and infarct size in late-presenting STEMI patients.
  • Good collateralization is associated with reduced long-term mortality in STEMI patients presenting 12-48 hours after symptom onset.
  • Coronary collateral status is a crucial independent predictor of long-term outcomes in STEMI.
Abstract

Related Concept Videos

Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
152
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
295
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
604
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
174
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
704
Angina III: Clinical Manifestations and Assessment01:29

Angina III: Clinical Manifestations and Assessment

Angina manifests as chest pain, tightness, or squeezing discomfort typically located behind the breastbone. It can radiate to the neck, jaw, shoulders, and inner aspects of the upper arms, most commonly the left arm. Patients may experience shortness of breath, fatigue, profuse sweating, dizziness, indigestion, heartburn, palpitations, anxiety, and vomiting as accompanying symptoms. This pain often lasts a few minutes and is triggered by physical exertion, emotional stress, heavy meals, or cold...
155